Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 |
filingDate |
2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54ea6cdd2f164addd80d8a49ea49f2cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d36e38065d69dee88cd4f84f32586c42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b132600642a521cda0c03e59e0dfee02 |
publicationDate |
2020-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-I710568-B |
titleOfInvention |
Anhydrous crystalline form of (1s)-1,5-anhydro-1-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-d-glucitol |
abstract |
The present invention is directed to an anhydrous crystalline for of (1S)-1,5-anhydro-1-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol, pharmaceutical compositions containing said anhydrous crystalline form and its use in the treatment glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. |
priorityDate |
2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |